Vyant Bio

About:

Vyant Bio is laboratory that develops and commercializes proprietary genomic tests and services to empower cancer treatment.

Website: https://www.vyantbio.com/

Twitter/X: vyantbio

Description:

Vyant Bio, Inc. (“Vyant Bio” or “Company”) operates two wholly-owned subsidiaries, StemoniX and vivoPharm. The Company is executing on the integration of these two leading businesses to integrate human-powered scientific and technology-based systems and expertise with years of preclinical experience to de-risk and accelerate discovery and development of preclinical and clinical pipelines for biopharma partners as well as for the proprietary pipeline of the Company.

Total Funding Amount:

$48.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Rutherford, New Jersey, United States

Founded Date:

1999-01-01

Contact Email:

Info(AT)VyantBio.com

Founders:

Raju S.K. Chaganti

Number of Employees:

51-100

Last Funding Date:

2021-02-10

IPO Status:

Public

Industries:

© 2025 bioDAO.ai